• Heidelberglaan 100, UMC Utrecht

      3584 CX Utrecht

      Netherlands

    20062024

    Research activity per year

    Personal profile

    Personal webpage

    Biography

    Karijn Suijkerbuijk is a translational medical oncologist with special interest in melanoma and immunotherapy. During her PhD, she performed research on tumor epigenetics in breast cancer in the lab of Professor Saraswati Sukumar at the Sidney Kimmel Cancer Center at Johns Hopkins University. Dr. Suijkerbuijk currently participates in multiple phase II and III clinical trials on immune checkpoint inhibitors. She published papers in Oncogene, Annals of Oncology and JNCI, received research grants from KWF and NWO and was awarded an ASCO Merit Award. Her current research focuses on clinical and immunological parameters assoaciated with immune related adverse events during checkpoint inhibition and clinicopathological factors associated with checkpoint inhibitor response.

    Fellowship & awards

    2007  Research year for residents (UU2007-3977) KWF
    2008  Translational grant KWF (UU-2008-4217
    2008  AGIKO stipend, ZonMW
    2008  ASCO Merit Award

    2018 ZonMW goed gebruik geneesmiddelen

    Side activities

    2023-... Scientific Steering Committee ESMO 2024 (melanoma track chair)

    2023-... Chair ESMO Melanoma Faculty

    2022-... Member ESMO Real World Data Working Group

    2022   Research funding Bristol Myers Squibb

    2021-.. Scientific advisory board Maarten vd Weijden foundation

    2021-..  ESMO melanoma faculty

    2021     Organizer and chair Oncode Melanoma Workshop

    2021     Reserach funding TigaTx

    2020-.. Data Safety Monitoring Board CHOPIN study (LUMC)

    2020    Data Safety Monitoring Board ICRA study (NKI)

    2020-..  Member Dutch working group Cancer in Pregnancy

    2020-.. Congress organization Immune-oncology symposium

    2020  Research funding Novartis

    2019-.. Scientific chair Dutch Melanoma Treatment Registry (DMTR)

    2019-.. Advisory board member patient society Stichting Melanoom

    2019-.. Board member Dutch Melanoma Tumor Focus Group

    2018-.. Invited discussant Medtalks

    Education/Academic qualification

    Associate Professor, University Medical Center (UMC) Utrecht

    Award Date: 1 Nov 2019

    External positions

    research funding Genmab - AI onderzoekssamenwerking in Health Holland project dat door Genmab financieel wordt ondersteund - Genmab

    1 Nov 202331 Dec 3999

    ESMO Melanoma Faculty Chair - melanoomexpertise - European Society for Medical Oncology

    1 Jan 202331 Dec 2024

    Scientific Steering Committee ESMO 2024 (melanoma track chair) - melanoom expertise - European Society for Medical Oncology

    1 Jan 202331 Dec 2024

    ESMO melanoma faculty - expertise melanoom - European Society for Medical Oncology

    13 Jun 202231 Dec 3999

    Lid real world data working group ESMO - onderzoek patientcohorten - European Society for Medical Oncology

    10 Jun 202231 Dec 3999

    Lid wetenschappelijke adviesraad - ervaring onderzoek - Maarten van der Weijden foundation

    10 Jun 202231 Dec 3999

    Adviesraad stichting melanoom (sinds 2019) - Vanuit expertise als melanoombehandelaar - Stichting melanoom

    9 Jun 202231 Dec 3999

    Lid Data Safety Monitoring Committee CHOPIN studie (vanaf 2020; studie gesponsord door BMS) - onderzoekservaring immuuntherapie - LUMC

    9 Jun 202231 Dec 3999

    Voorzitter wetenschappelijke commissie - Kwaliteitsverbetering en onderzoek op het gebied van melanoomzorg - Dutch Melanoma Treatment Registry (DICA)

    6 Jun 202231 Dec 3999

    Adviesgroep kanker in de zwangerschap - Expertise melanoom en immuuntherapie - Adviesgroep kanker in de zwangerschap

    1 Jun 202231 Dec 3999

    Onderzoeksfinanciering UNICIT-project door Bristol Myers Squibb - onderzoek immuuntherapie - UMC Utrecht

    1 Apr 20221 Jan 2025

    Organisatie/voorzitter jaarlijks immuno-oncologie symposium - expertise en onderzoek immuunoncologie - Immuno-oncologie symposium

    1 Jan 202031 Dec 3999

    Bestuurslid Tumorfocusgroep melanoom - expertise melanoom - Tumorfocusgroep melanoom

    1 Jan 201931 Dec 3999

    medisch expert bij melanoom nascholing en congresjournaal ASCO/ESMO - expertise melanoom - Medtalks

    1 Jan 201831 Dec 3999

    Collaborations and top research areas from the last five years

    Recent external collaboration on country/territory level. Dive into details by clicking on the dots or